Abstract
Novel assay techniques were applied to a newly developed microparticle‐based assay for C‐reactive protein (CRP). By using two different sized microparticles covalently coated with two monoclonal antibodies of different reactivity, high analytical sensitivity and a high upper measuring limit could be simultaneously attained, resulting in a remarkably wide dynamic range. This range was further increased by calculating the signal (reaction rate) optimally with a new software capability of COBAS® INTEGRA, a clinical chemistry analyzer. The assay showed high precision between 2 mg/l and 160 mg/l with use of only 2.5 μl specimen. The detection limit was estimated as 0.3 mg/l CRP. The assay was four to eight times more sensitive and precise than existing turbidimetric or nephelometric assays with comparable upper measuring limits. The assay also showed good linearity and correlated well with commercial assays. This new microparticle‐based CRP assay provides the accuracy and precision that are required to determine CRP at low concentrations where new clinical implications such as prognosis of cardiovascular diseases are envisaged. The assay's wide dynamic range will additionally lead to a reduction in the number of repeated analyses, thus improving the efficiency of CRP determinations in clinical laboratories. J. Clin. Lab. Anal. 12:137–144, 1998. © 1998 Wiley‐Liss, Inc.
Keywords: latex, immunoassay, monoclonal antibody, reactivity, particle size, mixing, inflammation, acute phase protein, angina pectoris, prognosis
References
- 1. Pepys MB, Baltz MC: Acute phase proteins with special reference to C‐reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol 34: 141–212, 1983. [DOI] [PubMed] [Google Scholar]
- 2. Liuzzo G, Biasucci LM, Gallimore JR, et al.: The prognostic value of C‐reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 331: 411–424, 1994. [DOI] [PubMed] [Google Scholar]
- 3. Haverkate F, Thompson SG, Pyke SDM, Gallimore JR, Pepys MB: Production of C‐reactive protein and risk of coronary events in stable and unstable angina. Lancet 349: 462–466, 1997. [DOI] [PubMed] [Google Scholar]
- 4. Peter A: Eine quantitative Methode zur Feindiagnostik von C‐reaktivem Protein mittelsmodifizierter radialer Immunodiffusion. Z Med Labortech 17: 198–202, 1976. [PubMed] [Google Scholar]
- 5. Otsuji S, Shibata H, Umeda M: Turbidimetric immunoassay of serum C‐reactive protein. Clin Chem 28: 2121–2124, 1982. [PubMed] [Google Scholar]
- 6. Kapmeyer W, Grenner G, Becker W: The nephelometric determination of C‐reactive protein, antistreptolysin O, and rheumatoid factors by latex agglutination tests. Clin Chem 29: 1189, 1983. (Abstract). [Google Scholar]
- 7. Price CP, Trull AK, Berry D, Gormann EG: Development and validation of a particle‐enhanced turbidimetric immunoassay for C‐reactive protein. J Immunol Methods 99: 205–211, 1987. [DOI] [PubMed] [Google Scholar]
- 8. Adam A, Ers P Hermann G, Stas JL: Analytical evaluation of a new latex agglutination test for quantitative determination of C‐reactive protein by laser nephelometry. J Clin Chem Clin Biochem 23: 787–789, 1985. [PubMed] [Google Scholar]
- 9. Lammers M, Bienvenu J, Monneret G, et al.: Evaluation of an improved immunonephelometric assay for C‐reactive protein. Clin Chem 42: S165, 1996. (Abstract). [Google Scholar]
- 10. Vigushin DM, Pepys MB, Hawkins PN: Metabolic and scintigraphic studies of radioiodinated human C‐reactive protein in health and disease. J Clin Invest 91: 1351–1357, 1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Galfrè G, Milstein C: Preparation of monoclonal antibodies: Strategies and procedures. Methods Enzymol 73: 3–46, 1981. [DOI] [PubMed] [Google Scholar]
- 12. Daiss JL, Scalice ER: Epitope mapping on BIAcore : Theoretical and practical considerations In Methods : A Companion to Methods in Enzymology. Abelson JN, Simon MI, Granzow R, eds. Academic Press, San Diego, 1994, p 143–156. [Google Scholar]
- 13. Fuentes‐Arderiu X: Clarification paper on sensitivity, detectability, and limit of detection. J Int Fed Clin Chem 4: 76–78, 1992. [Google Scholar]
- 14. Schumann G, Dati F: Vorläufige Referenzbereiche für 14 Proteins im Serum (für Erwachsene) nach Standardisierung immunochemischer Methoden unter Bezug auf das internationale Referenzmaterial CRM 470. Lab Med 19: 401–403, 1995. [Google Scholar]
- 15. Newmann DJ, Henneberry H, Price CP: Particle enhanced light scattering immunoassay. Ann Clin Biochem 29: 22–42, 1992. [DOI] [PubMed] [Google Scholar]
- 16. Schwartz MW, Schifreen RS, Gorman E, Tuhy PM, Bienvenu J, Warkentin DL: Development and performance of a fully automated method for assay of C‐reactive protein in the aca discrete clinical analyzer. Clin Chem 34: 1646–1649, 1988. [PubMed] [Google Scholar]